Aducanumab;AducanumabQ: What is
Aducanumab Q: What is the CAS Number of
Aducanumab;Research Grade Aducanumab(DHC12504);Aducanumab (anti-APP);BIIB037;Research Grade Aducanumab
用途
Aducanumab is an amyloid beta-directed antibody indicated for the treatment of Alzheimer's disease. It is approved for use in patients with mild cognitive impairment or mild dementia stage of the disease, based on the accelerated approval pathway due to its demonstrated reduction of amyloid beta plaques in the brain. The continued approval for this indication may depend on verification of clinical benefit in confirmatory trials.